Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gynecological Cancers Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Gynecological Cancers Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Cervical Cancer 1.4.3 Ovarian Cancer 1.4.4 Endometrial Cancer 1.4.5 Vaginal Cancer 1.4.6 Vulvar Cancer 1.4.7 Other 1.5 Market by Application 1.5.1 Global Gynecological Cancers Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Targeted Therapy 1.5.3 Chemotherapy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Gynecological Cancers Therapeutics Market Perspective (2015-2026) 2.2 Gynecological Cancers Therapeutics Growth Trends by Regions 2.2.1 Gynecological Cancers Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gynecological Cancers Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Gynecological Cancers Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gynecological Cancers Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Gynecological Cancers Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gynecological Cancers Therapeutics Players by Market Size 3.1.1 Global Top Gynecological Cancers Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Gynecological Cancers Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Gynecological Cancers Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gynecological Cancers Therapeutics Market Concentration Ratio 3.2.1 Global Gynecological Cancers Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gynecological Cancers Therapeutics Revenue in 2019 3.3 Gynecological Cancers Therapeutics Key Players Head office and Area Served 3.4 Key Players Gynecological Cancers Therapeutics Product Solution and Service 3.5 Date of Enter into Gynecological Cancers Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gynecological Cancers Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Gynecological Cancers Therapeutics Forecasted Market Size by Type (2021-2026) 5 Gynecological Cancers Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 5.2 Global Gynecological Cancers Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gynecological Cancers Therapeutics Market Size (2015-2020) 6.2 Gynecological Cancers Therapeutics Key Players in North America (2019-2020) 6.3 North America Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 6.4 North America Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gynecological Cancers Therapeutics Market Size (2015-2020) 7.2 Gynecological Cancers Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 7.4 Europe Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Gynecological Cancers Therapeutics Market Size (2015-2020) 8.2 Gynecological Cancers Therapeutics Key Players in China (2019-2020) 8.3 China Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 8.4 China Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Gynecological Cancers Therapeutics Market Size (2015-2020) 9.2 Gynecological Cancers Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 9.4 Japan Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Gynecological Cancers Therapeutics Market Size (2015-2020) 10.2 Gynecological Cancers Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Gynecological Cancers Therapeutics Market Size (2015-2020) 11.2 Gynecological Cancers Therapeutics Key Players in India (2019-2020) 11.3 India Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 11.4 India Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Gynecological Cancers Therapeutics Market Size (2015-2020) 12.2 Gynecological Cancers Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Gynecological Cancers Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Gynecological Cancers Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 AstraZeneca 13.1.1 AstraZeneca Company Details 13.1.2 AstraZeneca Business Overview and Its Total Revenue 13.1.3 AstraZeneca Gynecological Cancers Therapeutics Introduction 13.1.4 AstraZeneca Revenue in Gynecological Cancers Therapeutics Business (2015-2020)) 13.1.5 AstraZeneca Recent Development 13.2 Bristol-Myers Squibb Company 13.2.1 Bristol-Myers Squibb Company Company Details 13.2.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 13.2.3 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Introduction 13.2.4 Bristol-Myers Squibb Company Revenue in Gynecological Cancers Therapeutics Business (2015-2020) 13.2.5 Bristol-Myers Squibb Company Recent Development 13.3 F. Hoffmann-La Roche Ltd 13.3.1 F. Hoffmann-La Roche Ltd Company Details 13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue 13.3.3 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Introduction 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancers Therapeutics Business (2015-2020) 13.3.5 F. Hoffmann-La Roche Ltd Recent Development 13.4 GlaxoSmithKline plc 13.4.1 GlaxoSmithKline plc Company Details 13.4.2 GlaxoSmithKline plc Business Overview and Its Total Revenue 13.4.3 GlaxoSmithKline plc Gynecological Cancers Therapeutics Introduction 13.4.4 GlaxoSmithKline plc Revenue in Gynecological Cancers Therapeutics Business (2015-2020) 13.4.5 GlaxoSmithKline plc Recent Development 13.5 Merck & Co., Inc. 13.5.1 Merck & Co., Inc. Company Details 13.5.2 Merck & Co., Inc. Business Overview and Its Total Revenue 13.5.3 Merck & Co., Inc. Gynecological Cancers Therapeutics Introduction 13.5.4 Merck & Co., Inc. Revenue in Gynecological Cancers Therapeutics Business (2015-2020) 13.5.5 Merck & Co., Inc. Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Gynecological Cancers Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Gynecological Cancers Therapeutics Revenue Table 3. Ranking of Global Top Gynecological Cancers Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gynecological Cancers Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Cervical Cancer Table 6. Key Players of Ovarian Cancer Table 7. Key Players of Endometrial Cancer Table 8. Key Players of Vaginal Cancer Table 9. Key Players of Vulvar Cancer Table 10. Key Players of Other Table 11. Global Gynecological Cancers Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 12. Global Gynecological Cancers Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 13. Global Gynecological Cancers Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 14. Global Gynecological Cancers Therapeutics Market Share by Regions (2015-2020) Table 15. Global Gynecological Cancers Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 16. Global Gynecological Cancers Therapeutics Market Share by Regions (2021-2026) Table 17. Market Top Trends Table 18. Key Drivers: Impact Analysis Table 19. Key Challenges Table 20. Gynecological Cancers Therapeutics Market Growth Strategy Table 21. Main Points Interviewed from Key Gynecological Cancers Therapeutics Players Table 22. Global Gynecological Cancers Therapeutics Revenue by Players (2015-2020) (Million US$) Table 23. Global Gynecological Cancers Therapeutics Market Share by Players (2015-2020) Table 24. Global Top Gynecological Cancers Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecological Cancers Therapeutics as of 2019) Table 25. Global Gynecological Cancers Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Gynecological Cancers Therapeutics Product Solution and Service Table 28. Date of Enter into Gynecological Cancers Therapeutics Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 31. Global Gynecological Cancers Therapeutics Market Size Share by Type (2015-2020) Table 32. Global Gynecological Cancers Therapeutics Revenue Market Share by Type (2021-2026) Table 33. Global Gynecological Cancers Therapeutics Market Size Share by Application (2015-2020) Table 34. Global Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 35. Global Gynecological Cancers Therapeutics Market Size Share by Application (2021-2026) Table 36. North America Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 37. North America Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 38. North America Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 39. North America Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 40. North America Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 41. North America Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 42. Europe Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 43. Europe Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 44. Europe Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 45. Europe Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 46. Europe Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 47. Europe Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 48. China Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 49. China Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 50. China Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 51. China Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 52. China Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 53. China Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 54. Japan Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 55. Japan Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 56. Japan Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 57. Japan Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 58. Japan Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 59. Japan Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 60. Southeast Asia Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 61. Southeast Asia Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 62. Southeast Asia Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 63. Southeast Asia Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 64. Southeast Asia Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 65. Southeast Asia Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 66. India Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 67. India Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 68. India Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 69. India Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 70. India Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 71. India Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 72. Central & South America Key Players Gynecological Cancers Therapeutics Revenue (2019-2020) (Million US$) Table 73. Central & South America Key Players Gynecological Cancers Therapeutics Market Share (2019-2020) Table 74. Central & South America Gynecological Cancers Therapeutics Market Size by Type (2015-2020) (Million US$) Table 75. Central & South America Gynecological Cancers Therapeutics Market Share by Type (2015-2020) Table 76. Central & South America Gynecological Cancers Therapeutics Market Size by Application (2015-2020) (Million US$) Table 77. Central & South America Gynecological Cancers Therapeutics Market Share by Application (2015-2020) Table 78. AstraZeneca Company Details Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Product Table 81. AstraZeneca Revenue in Gynecological Cancers Therapeutics Business (2015-2020) (Million US$) Table 82. AstraZeneca Recent Development Table 83. Bristol-Myers Squibb Company Company Details Table 84. Bristol-Myers Squibb Company Business Overview Table 85. Bristol-Myers Squibb Company Product Table 86. Bristol-Myers Squibb Company Revenue in Gynecological Cancers Therapeutics Business (2015-2020) (Million US$) Table 87. Bristol-Myers Squibb Company Recent Development Table 88. F. Hoffmann-La Roche Ltd Company Details Table 89. F. Hoffmann-La Roche Ltd Business Overview Table 90. F. Hoffmann-La Roche Ltd Product Table 91. F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancers Therapeutics Business (2015-2020) (Million US$) Table 92. F. Hoffmann-La Roche Ltd Recent Development Table 93. GlaxoSmithKline plc Company Details Table 94. GlaxoSmithKline plc Business Overview Table 95. GlaxoSmithKline plc Product Table 96. GlaxoSmithKline plc Revenue in Gynecological Cancers Therapeutics Business (2015-2020) (Million US$) Table 97. GlaxoSmithKline plc Recent Development Table 98. Merck & Co., Inc. Company Details Table 99. Merck & Co., Inc. Business Overview Table 100. Merck & Co., Inc. Product Table 101. Merck & Co., Inc. Revenue in Gynecological Cancers Therapeutics Business (2015-2020) (Million US$) Table 102. Merck & Co., Inc. Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Gynecological Cancers Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Cervical Cancer Features Figure 3. Ovarian Cancer Features Figure 4. Endometrial Cancer Features Figure 5. Vaginal Cancer Features Figure 6. Vulvar Cancer Features Figure 7. Other Features Figure 8. Global Gynecological Cancers Therapeutics Market Share by Application: 2020 VS 2026 Figure 9. Targeted Therapy Case Studies Figure 10. Chemotherapy Case Studies Figure 11. Gynecological Cancers Therapeutics Report Years Considered Figure 12. Global Gynecological Cancers Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Gynecological Cancers Therapeutics Market Share by Regions: 2020 VS 2026 Figure 14. Global Gynecological Cancers Therapeutics Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Gynecological Cancers Therapeutics Market Share by Players in 2019 Figure 17. Global Top Gynecological Cancers Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecological Cancers Therapeutics as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Gynecological Cancers Therapeutics Revenue in 2019 Figure 19. North America Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Gynecological Cancers Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. AstraZeneca Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2015-2020) Figure 28. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Bristol-Myers Squibb Company Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2015-2020) Figure 30. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2015-2020) Figure 32. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. GlaxoSmithKline plc Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2015-2020) Figure 34. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Merck & Co., Inc. Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

AstraZeneca Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd GlaxoSmithKline plc Merck & Co., Inc.